Tempus AI Other Long-Term Assets 2023-2025 | TEM

Tempus AI other long-term assets from 2023 to 2025. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Tempus AI other long-term assets for the quarter ending March 31, 2025 were $0.002B, a 92.8% decline year-over-year.
  • Tempus AI other long-term assets for 2024 were $0.001B, a 96.77% decline from 2023.
  • Tempus AI other long-term assets for 2023 were $0.027B, a 5.94% increase from 2022.
  • Tempus AI other long-term assets for 2022 were $0.026B, a 0% decline from .
Tempus AI Annual Other Long-Term Assets
(Millions of US $)
2024 $1
2023 $27
2022 $26
Tempus AI Quarterly Other Long-Term Assets
(Millions of US $)
2025-03-31 $2
2024-12-31 $1
2024-09-30 $19
2024-06-30 $21
2024-03-31 $24
2023-12-31 $27
2023-09-30
2023-06-30
2023-03-31
2022-12-31 $26
Sector Industry Market Cap Revenue
Medical Medical Information Systems $10.204B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.320B 52.93
Hims & Hers Health (HIMS) United States $11.979B 124.46
IRhythm Technologies (IRTC) United States $4.547B 0.00
Inspire Medical Systems (INSP) United States $4.305B 67.26
Privia Health (PRVA) United States $2.816B 192.50
Enovis (ENOV) United States $1.849B 10.31
Clover Health Investments (CLOV) United States $1.669B 0.00
Schrodinger (SDGR) United States $1.550B 0.00
Phreesia (PHR) United States $1.447B 0.00
Omnicell (OMCL) United States $1.351B 23.83
Azenta (AZTA) United States $1.283B 59.64
10x Genomics (TXG) United States $1.052B 0.00
Fulgent Genetics (FLGT) United States $0.625B 0.00
Butterfly Network (BFLY) United States $0.529B 0.00
Claritev (CTEV) United States $0.479B 0.00
Veradigm (MDRX) United States $0.476B 0.00
Talkspace (TALK) United States $0.462B 138.00
Standard BioTools (LAB) United States $0.363B 0.00
TruBridge (TBRG) United States $0.356B 789.67
Outset Medical (OM) United States $0.327B 0.00
Nyxoah SA (NYXH) Belgium $0.283B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.193B 0.00
EUDA Health Holdings (EUDA) Singapore $0.136B 0.00
Pulmonx (LUNG) United States $0.126B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.097B 0.00
CareCloud (CCLD) United States $0.087B 3.31
111 (YI) China $0.067B 0.00
P3 Health Partners (PIII) United States $0.055B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Retrieve Medical Holdings (RMHI) United States $0.051B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00